Skip to main content
Rachel (Sahn) Hill, MD, Dermatology, Charleston, SC

Rachel(Sahn)HillMD

Dermatology Charleston, SC

Physician

Dr. Hill is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hill's full profile

Already have an account?

  • Office

    225 Seven Farms Dr
    Ste 105
    Charleston, SC 29492
    Phone+1 843-971-4460
    Fax+1 843-971-0991

Summary

  • Dr. Rachel Hill is a Dermatologist in Charleston, SC. She received her medical degree from Medical University of South Carolina College of Medicine and has been in practice 10 years. She is experienced in general, pediatric, cosmetic and surgical dermatology. She has 5 publications.

Education & Training

  • Emory University School of Medicine
    Emory University School of MedicineResidency, Dermatology, 2011 - 2014
  • Emory University School of Medicine
    Emory University School of MedicineFellowship, Research, 2010 - 2011
  • Medical University of South Carolina
    Medical University of South CarolinaInternship, Internal Medicine, 2009 - 2010
  • Medical University of South Carolina
    Medical University of South CarolinaClass of 2009

Certifications & Licensure

  • SC State Medical License
    SC State Medical License 2014 - 2025
  • GA State Medical License
    GA State Medical License 2010 - 2015
  • American Board of Dermatology Dermatology

Publications & Presentations

PubMed

Journal Articles

  • Acitretin for the treatment of cutaneous T-cell lymphoma  
    Cheeley J, Sahn RE, DeLong LK, Parker SR, J Am Acad Dermatol, 2/2013
  • Cutaneous manifestations of internal malignancy  
    Thiers BH, Sahn RE, Callen JP, CA Cancer J Clin, 3/2009

Press Mentions

  • Study Finds No Increased Cancer Risk with Spironolactone
    Study Finds No Increased Cancer Risk with SpironolactoneMarch 1st, 2024

Professional Memberships